- Home
- LNTH vs CAAP Comparison
LNTH vs CAAP Comparison
Compare LNTH & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- CAAP
- Stock Information
- Founded
- LNTH 1956
- CAAP 1998
- Country
- LNTH United States
- CAAP Luxembourg
- Employees
- LNTH N/A
- CAAP N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CAAP Aerospace
- Sector
- LNTH Health Care
- CAAP Consumer Discretionary
- Exchange
- LNTH Nasdaq
- CAAP Nasdaq
- Market Cap
- LNTH 3.6B
- CAAP 3.1B
- IPO Year
- LNTH 2015
- CAAP 2018
- Fundamental
- Price
- LNTH $52.99
- CAAP $19.38
- Analyst Decision
- LNTH Strong Buy
- CAAP Strong Buy
- Analyst Count
- LNTH 5
- CAAP 2
- Target Price
- LNTH $91.60
- CAAP $24.35
- AVG Volume (30 Days)
- LNTH 1.6M
- CAAP 207.4K
- Earning Date
- LNTH 11-05-2025
- CAAP 08-20-2025
- Dividend Yield
- LNTH N/A
- CAAP N/A
- EPS Growth
- LNTH N/A
- CAAP N/A
- EPS
- LNTH 3.77
- CAAP 0.93
- Revenue
- LNTH $1,520,653,000.00
- CAAP $1,873,095,000.00
- Revenue This Year
- LNTH N/A
- CAAP $1.18
- Revenue Next Year
- LNTH $3.24
- CAAP $12.98
- P/E Ratio
- LNTH $14.58
- CAAP $21.49
- Revenue Growth
- LNTH 5.75
- CAAP 26.88
- 52 Week Low
- LNTH $47.25
- CAAP $14.80
- 52 Week High
- LNTH $118.21
- CAAP $22.85
- Technical
- Relative Strength Index (RSI)
- LNTH 38.84
- CAAP 41.14
- Support Level
- LNTH $51.94
- CAAP $18.82
- Resistance Level
- LNTH $55.24
- CAAP $20.47
- Average True Range (ATR)
- LNTH 1.97
- CAAP 0.75
- MACD
- LNTH 0.48
- CAAP -0.23
- Stochastic Oscillator
- LNTH 15.34
- CAAP 17.65
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.